Lack of metabolic effects of a triphasic formulation containing norethindrone in normal women studied prospectively.
Crook
D
D
Godsland
I F
IF
Wynn
V
V
D050260:Carbohydrate Metabolism; D005260:Female; D006801:Humans; D050356:Lipid Metabolism; D009640:Norethindrone / Q000009:adverse effects*
D009640:Norethindrone